1. Home
  2. AXSM vs BMA Comparison

AXSM vs BMA Comparison

Compare AXSM & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • BMA
  • Stock Information
  • Founded
  • AXSM 2012
  • BMA 1966
  • Country
  • AXSM United States
  • BMA Argentina
  • Employees
  • AXSM N/A
  • BMA N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • BMA Commercial Banks
  • Sector
  • AXSM Health Care
  • BMA Finance
  • Exchange
  • AXSM Nasdaq
  • BMA Nasdaq
  • Market Cap
  • AXSM 5.9B
  • BMA 5.5B
  • IPO Year
  • AXSM 2015
  • BMA 2006
  • Fundamental
  • Price
  • AXSM $145.72
  • BMA $79.60
  • Analyst Decision
  • AXSM Strong Buy
  • BMA Strong Buy
  • Analyst Count
  • AXSM 20
  • BMA 6
  • Target Price
  • AXSM $176.00
  • BMA $81.70
  • AVG Volume (30 Days)
  • AXSM 547.8K
  • BMA 829.4K
  • Earning Date
  • AXSM 11-03-2025
  • BMA 11-26-2025
  • Dividend Yield
  • AXSM N/A
  • BMA 2.20%
  • EPS Growth
  • AXSM N/A
  • BMA N/A
  • EPS
  • AXSM N/A
  • BMA 0.50
  • Revenue
  • AXSM $561,263,000.00
  • BMA $2,573,406,817.00
  • Revenue This Year
  • AXSM $63.66
  • BMA N/A
  • Revenue Next Year
  • AXSM $54.46
  • BMA $3.01
  • P/E Ratio
  • AXSM N/A
  • BMA $16.95
  • Revenue Growth
  • AXSM 65.83
  • BMA N/A
  • 52 Week Low
  • AXSM $75.56
  • BMA $38.30
  • 52 Week High
  • AXSM $146.53
  • BMA $118.42
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 72.66
  • BMA 58.45
  • Support Level
  • AXSM $136.00
  • BMA $79.18
  • Resistance Level
  • AXSM $144.15
  • BMA $89.29
  • Average True Range (ATR)
  • AXSM 5.82
  • BMA 5.21
  • MACD
  • AXSM 0.32
  • BMA -1.37
  • Stochastic Oscillator
  • AXSM 99.54
  • BMA 4.20

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

Share on Social Networks: